BAX vs. GH: Baxter vs. Guardant Health Stock Comparison

Company Profile

Baxter (BAX) and Guardant Health (GH) both fall under the Health Care Equipment & Services industry group, but BAX is classified in Health Care Equipment & Supplies while GH is classified in Health Care Providers & Services.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Guardant Health (GH) has an aggressive beta of 1.69, indicating higher sensitivity to broad-market moves, while Baxter (BAX) is defensive at 0.62 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Guardant Health (GH) has no ROE value reported for this period; Baxter (BAX) reports a negative figure of -9.04%, which needs context because negative ROE can reflect losses or negative shareholders’ equity.

Both Baxter (BAX) at -6.23% and Guardant Health (GH) at -37.93% report negative net margin values, usually indicating net losses over the period.

Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Baxter (BAX) reports 9.88%, ranking against industry peers normally.

Profitability Metrics

Growth

Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while Baxter (BAX) at 5.72% is closer to the peer norm — faster top-line expansion for GH.

Neither Baxter (BAX) nor Guardant Health (GH) reports a EPS growth value for this period, so a direct comparison isn't possible.

Growth Metrics

Financial Strength

Both Baxter (BAX) at 1.79 and Guardant Health (GH) at 3.60 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Only one side’s leverage can be read here: Baxter (BAX) carries debt-to-equity ratio of 1.36 against its industry range, while Guardant Health (GH) reports no figure this period.

Financial Strength Metrics

Dividends

Guardant Health (GH) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Baxter (BAX) reports a yield of 0.16%, ranking against industry peers normally.

Baxter (BAX) reports payout ratio above 100% at 154.67%, meaning dividends exceeded current-period earnings; Guardant Health (GH) pays no dividend (payout 0.00%).

Dividend Metrics

Valuation

Neither Baxter (BAX) nor Guardant Health (GH) reports a P/E ratio value for this period, so a direct comparison isn’t possible.

Baxter (BAX) at 1.15 prices around its industry’s typical P/S ratio, while Guardant Health (GH) at 15.96 clears its benchmark range — GH looks notably rich on sales.

Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Baxter (BAX) reports 2.05, ranking against industry peers normally.

Valuation Metrics